| GO ID | GO name | Interaction type | Reference |
|---|---|---|---|
| GO:0003993 | Acid phosphatase activity | Increases phenotype | PMID:28710019 |
| GO:0004784 | Superoxide dismutase activity | Increases phenotype | PMID:31456356; PMID:32856796 |
| GO:0005243 | Gap junction channel activity | Decreases phenotype | PMID:26023933 |
| GO:0006749 | Glutathione metabolic process | Increases phenotype | PMID:29526570; PMID:31181217; PMID:34453960 |
| GO:0006974 | Cellular response to dna damage stimulus | Increases phenotype | PMID:31456356 |
| GO:0007033 | Vacuole organization | Increases phenotype | PMID:31456356 |
| GO:0007204 | Positive regulation of cytosolic calcium ion concentration | Increases phenotype | PMID:20238386 |
| GO:0008219 | Cell death | Increases phenotype | PMID:29502740 |
| GO:0008283 | Cell population proliferation | Increases phenotype | PMID:28710019 |
| GO:0008285 | Negative regulation of cell population proliferation | Increases phenotype | PMID:29526570 |
| GO:0010729 | Positive regulation of hydrogen peroxide biosynthetic process | Increases phenotype | PMID:20238386 |
| GO:0010940 | Positive regulation of necrotic cell death | Increases phenotype | PMID:31181217 |
| GO:0010942 | Positive regulation of cell death | Increases phenotype | PMID:20238386 |
| GO:0016042 | Lipid catabolic process | Increases phenotype | PMID:31456356; PMID:32856796 |
| GO:0018158 | Protein oxidation | Decreases phenotype | PMID:20238386 |
| GO:0021766 | Hippocampus development | Affects phenotype | PMID:34453960 |
| GO:0031325 | Positive regulation of cellular metabolic process | Increases phenotype | PMID:28803881 |
| GO:0032125 | Micronucleus organization | Increases phenotype | PMID:29502740 |
| GO:0032930 | Positive regulation of superoxide anion generation | Increases phenotype | PMID:20238386 |
| GO:0034440 | Lipid oxidation | Increases phenotype | PMID:20238386 |
| GO:0035176 | Social behavior | Decreases phenotype | PMID:34453960 |
| GO:0035640 | Exploration behavior | Decreases phenotype | PMID:34453960 |
| GO:0043433 | Negative regulation of dna-binding transcription factor activity | Increases phenotype | PMID:26022396 |
| GO:0044237 | Cellular metabolic process | Decreases phenotype | PMID:32856796; PMID:33359405 |
| GO:0045429 | Positive regulation of nitric oxide biosynthetic process | Increases phenotype | PMID:20238386 |
| GO:0045454 | Cell redox homeostasis | Decreases phenotype | PMID:20238386 |
| GO:0050765 | Negative regulation of phagocytosis | Increases phenotype | PMID:20238386 |
| GO:0050847 | Progesterone receptor signaling pathway | Decreases phenotype | PMID:26022396 |
| GO:0070959 | Negative regulation of neutrophil mediated killing of fungus | Increases phenotype | PMID:20238386 |
| GO:0072593 | Reactive oxygen species metabolic process | Increases phenotype | PMID:12730081; PMID:32856796; PMID:34453960 |
| GO:1900119 | Positive regulation of execution phase of apoptosis | Increases phenotype | PMID:29526570 |
| GO:1900182 | Positive regulation of protein localization to nucleus | Increases phenotype | PMID:31181217 |
| GO:1901670 | Negative regulation of superoxide dismutase activity | Increases phenotype | PMID:29526570 |
| GO:1901671 | Positive regulation of superoxide dismutase activity | Increases phenotype | PMID:20238386 |
| GO:1903284 | Positive regulation of glutathione peroxidase activity | Increases phenotype | PMID:20238386 |
| GO:1903428 | Positive regulation of reactive oxygen species biosynthetic process | Increases phenotype | PMID:29526570 |
| GO:1990266 | Neutrophil migration | Increases phenotype | PMID:31456356 |
| GO:2000865 | Negative regulation of estradiol secretion | Increases phenotype | PMID:28803881 |
| GO:2000871 | Negative regulation of progesterone secretion | Increases phenotype | PMID:28803881 |
We have built a comprehensive resource which compiles potential endocrine disrupting chemicals (EDCs) based on the observed adverse effects or endocrine-mediated endpoints in published experiments on humans or rodents to support basic research. We are not responsible for any errors or omissions in the published research articles or supporting literature on potential EDCs compiled in this resource. Users are advised to exercise their own judgement on the weight of evidence for potential EDCs compiled in this resource. Importantly, our sole goal to build this resource on potential EDCs is to enable future basic research towards better understanding of the systems-level perturbations upon chemical exposure rather than influencing regulatory advice on chemical use.